Back
Zevra Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
ZVRA
Zevra Therapeutics
Last Price:
$7.21
Seasonality Move:
0.78%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZVRA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Zevra Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.13 | Buy |
| 20-day SMA: | 7.14 | Buy |
| 50-day SMA: | 7.59 | Sell |
| 200-day SMA: | 7.79 | Sell |
| 8-day EMA: | 7.15 | Buy |
| 20-day EMA: | 7.23 | Sell |
| 50-day EMA: | 7.51 | Sell |
| 200-day EMA: | 7.46 | Sell |
Zevra Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 47.71 | Sell |
| Chaikin Money Flow: | 336410 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.86 - 7.78) | Sell |
| Bollinger Bands (100): | (7.35 - 8.57) | Sell |
Zevra Therapeutics Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Zevra Therapeutics Stock
Is Zevra Therapeutics Stock a Buy?
-
Zevra Therapeutics share price is 7.20 while ZVRA 8-day simple moving average is 7.13, which is a Buy signal.
-
The stock price of ZVRA is 7.20 while Zevra Therapeutics 20-day SMA is 7.14, which makes it a Buy.
-
Zevra Therapeutics 50-day simple moving average is 7.59 while ZVRA share price is 7.20, making it a Sell technically.
-
ZVRA stock price is 7.20 and Zevra Therapeutics 200-day simple moving average is 7.79, creating a Sell signal.
ZVRA Technical Analysis vs Fundamental Analysis
Sell
30
Zevra Therapeutics (ZVRA)
is a Sell
Is Zevra Therapeutics a Buy or a Sell?
-
Zevra Therapeutics stock is rated a SellThe current Zevra Therapeutics [ZVRA] share price is $7.20. The Score for ZVRA is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Zevra Therapeutics Stock Info
Market Cap:
389.6M
Price in USD:
7.20
Share Volume:
381.3K
Zevra Therapeutics 52-Week Range
52-Week High:
9.76
52-Week Low:
4.20
Sell
30
Zevra Therapeutics (ZVRA)
is a Sell
Zevra Therapeutics Share Price Forecast
-
What is the Zevra Therapeutics stock price today?The Zevra Therapeutics stock price is 7.20 USD today.
-
Will ZVRA stock go up or go down?Zevra Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Zevra Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Zevra Therapeutics is overvalued.
Is Zevra Therapeutics Stock a Buy?
-
Zevra Therapeutics share price is 7.20 while ZVRA 8-day exponential moving average is 7.15, which is a Buy signal.
-
The stock price of ZVRA is 7.20 while Zevra Therapeutics 20-day EMA is 7.23, which makes it a Sell.
-
Zevra Therapeutics 50-day exponential moving average is 7.51 while ZVRA share price is 7.20, making it a Sell technically.
-
ZVRA stock price is 7.20 and Zevra Therapeutics 200-day simple moving average is 7.46, creating a Sell signal.
Fundamental Analysis of Zevra Therapeutics
Is Zevra Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.04 per share, and an increase next year of $0.54 per share.
Technical Analysis of Zevra Therapeutics
Should I short Zevra Therapeutics stock?
-
ZVRA Moving Average Covergence Divergence (MACD) indicator is -0.14, suggesting Zevra Therapeutics is a Sell
-
Zevra Therapeutics Relative Strength Index (RSI) is 47.71, which suggest Zevra Therapeutics is oversold
-
The Bollinger Bands (25) for Zevra Therapeutics is (6.86 - 7.78), which suggest Zevra Therapeutics is a Sell
-
The Bollinger Bands (100) for Zevra Therapeutics is (7.35 - 8.57), which suggest Zevra Therapeutics is a Sell
* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.